Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Rigo

Showing results (61-70 of 163) with videos related to

Pageof 17
Sort By:
Nucleic Acid Therapeutics|September 29, 2025
A Workflow for Transcriptome-Wide Assessment of Antisense Oligonucleotide SelectivitySagar S Damle, Andy Watt, Steven Kuntz, et al.
American Journal of Human Genetics|June 25, 2019
NCALD Antisense Oligonucleotide Therapy in Addition to Nusinersen further Ameliorates Spinal Muscular Atrophy in MiceLaura Torres-Benito, Svenja Schneider, Roman Rombo, et al.
Cell Reports|September 30, 2016
Mammary Tumor-Associated RNAs Impact Tumor Cell Proliferation, Invasion, and MigrationSarah D Diermeier, Kung-Chi Chang, Susan M Freier, et al.
Nucleic Acids Research|September 30, 2016
Antisense oligonucleotides delivered to the amniotic cavity in utero modulate gene expression in the postnatal mouseFrederic F Depreux, Lingyan Wang, Han Jiang, et al.
Human Molecular Genetics|June 5, 2015
DICER/AGO-dependent epigenetic silencing of D4Z4 repeats enhanced by exogenous siRNA suggests mechanisms and therapies for FSHDJong-Won Lim, Lauren Snider, Zizhen Yao, et al.
Frontiers in Neurology|July 15, 2021
Antisense Oligonucleotide-Mediated Reduction of HDAC6 Does Not Reduce Tau Pathology in P301S Tau Transgenic MiceAntonio Valencia, Veronica L Reinhart Bieber, Bekim Bajrami, et al.
Gene Therapy|January 25, 2022
Antisense oligonucleotides as a potential treatment for brain deficits observed in myotonic dystrophy type 1Siham Ait Benichou, Dominic Jauvin, Thiéry De Serres-Bérard, et al.
Nucleic Acid Therapeutics|March 24, 2020
Delivery of Antisense Oligonucleotides to the CorneaViet Q Chau, Jiaxin Hu, Xin Gong, et al.
Brain : a Journal of Neurology|November 30, 2018
Frontotemporal dementia causative CHMP2B impairs neuronal endolysosomal traffic-rescue by TMEM106B knockdownEmma L Clayton, Carmelo Milioto, Bhavana Muralidharan, et al.
JCI Insight|December 7, 2021
Astrocytic 4R tau expression drives astrocyte reactivity and dysfunctionLubov A Ezerskiy, Kathleen M Schoch, Chihiro Sato, et al.
Pageof 17

Showing results (61-70 of 163) with videos related to

Sort By:
Pageof 17
Nucleic Acid Therapeutics|September 29, 2025
A Workflow for Transcriptome-Wide Assessment of Antisense Oligonucleotide SelectivitySagar S Damle, Andy Watt, Steven Kuntz, et al.
American Journal of Human Genetics|June 25, 2019
NCALD Antisense Oligonucleotide Therapy in Addition to Nusinersen further Ameliorates Spinal Muscular Atrophy in MiceLaura Torres-Benito, Svenja Schneider, Roman Rombo, et al.
Cell Reports|September 30, 2016
Mammary Tumor-Associated RNAs Impact Tumor Cell Proliferation, Invasion, and MigrationSarah D Diermeier, Kung-Chi Chang, Susan M Freier, et al.
Nucleic Acids Research|September 30, 2016
Antisense oligonucleotides delivered to the amniotic cavity in utero modulate gene expression in the postnatal mouseFrederic F Depreux, Lingyan Wang, Han Jiang, et al.
Human Molecular Genetics|June 5, 2015
DICER/AGO-dependent epigenetic silencing of D4Z4 repeats enhanced by exogenous siRNA suggests mechanisms and therapies for FSHDJong-Won Lim, Lauren Snider, Zizhen Yao, et al.
Frontiers in Neurology|July 15, 2021
Antisense Oligonucleotide-Mediated Reduction of HDAC6 Does Not Reduce Tau Pathology in P301S Tau Transgenic MiceAntonio Valencia, Veronica L Reinhart Bieber, Bekim Bajrami, et al.
Gene Therapy|January 25, 2022
Antisense oligonucleotides as a potential treatment for brain deficits observed in myotonic dystrophy type 1Siham Ait Benichou, Dominic Jauvin, Thiéry De Serres-Bérard, et al.
Nucleic Acid Therapeutics|March 24, 2020
Delivery of Antisense Oligonucleotides to the CorneaViet Q Chau, Jiaxin Hu, Xin Gong, et al.
Brain : a Journal of Neurology|November 30, 2018
Frontotemporal dementia causative CHMP2B impairs neuronal endolysosomal traffic-rescue by TMEM106B knockdownEmma L Clayton, Carmelo Milioto, Bhavana Muralidharan, et al.
JCI Insight|December 7, 2021
Astrocytic 4R tau expression drives astrocyte reactivity and dysfunctionLubov A Ezerskiy, Kathleen M Schoch, Chihiro Sato, et al.
Pageof 17